![](/img/cover-not-exists.png)
Regular dosing of zoledronic acid maintains continuous suppression of osteolysis in patients with malignant bone disease
Horst Schran, Christina Ravera, Andrej Skerjanec, Manon BoisclairVolume:
42
Year:
2008
Language:
english
Pages:
1
DOI:
10.1016/j.bone.2007.12.209
File:
PDF, 71 KB
english, 2008